For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.

The fight against Alzheimer's disease was dealt yet another setback on Monday.

Two late-stage treatment studies conducted by Roche, which the pharma giant once hoped to be a miracle drug for more than 24 million people around the world, have failed. The twin blows are just the latest upset for neurologists battling the hated disease.

Continue reading

Source Fool.com